N-Boc-D-proline

We are N-Boc-D-proline CAS:19746-37-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-Boc-D-proline
CAS.NO: 19746-37-3
Molecular Formula:C11H20N2O5S
Molecular Weight: 292.35200

Synonyms:
boc-Cys(Acm)-OH
Boc-S-acetamidomethyl-L-cysteine
boc-Cys(Acm)
L-N-Boc-Cys-acetamidomethyl
EINECS 243-267-0
N-t-butoxycarbonyl-S-acetamidomethyl-L-cysteine
Boc-L-Cys(Acm)-OH
S-(Acetylaminomethyl)-N-(tert-butyloxycarbonyl)-L-cysteine
(R)-3-((Acetamidomethyl)thio)-2-((tert-butoxycarbonyl)amino)propanoic acid
S-(Acetamidomethyl)-N-(tert-butoxycarbonyl)-L-cysteine
N-Boc-Cys(Acm)-OH
Boc-S-acetaminomethyl-L-cysteine

Physical and Chemical Properties:
Density: 1.231 g / cm3
Boiling point: 531.5ºC at 760mmHg
Melting point: 111-114 ° C
Flash point: 275.2ºC
Refractive index: 1.514

Specification:
Appearance: White powder
Purity:≥98%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:-20ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.

N-Boc-D-proline


Related News: API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine.2-metilprop-2-enoato de furan-2-ilmetilo CAS:3454-28-2 In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.methyl 3-bromo-2-fluorobenzoate CAS:206551-41-9 “We believe such actions are our last resort,” the Hospital Authority Employees Alliance, a union that formed during the city’s antigovernment protest movement, wrote in a statement.Ethyl arachidonate CAS:1808-26-0 Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.Fate Therapeutics, Inc. recently announced new in vivo preclinical data for FT819, its first off-the-shelf, iPSC-derived chimeric antigen receptor (CAR) T-cell product candidate, at the 61st American Society of Hematology (ASH) Meeting and Exposition in Orlando, FL.

Related Products
Product Name
(1R,2S)-1-tert-Butoxycarbonylamino-2-vinylcyclopropanecarboxylic acid View Details
6-Chloro-2-picoline View Details
4-Hydrazino-N-methylbenzenemethanesulfonamide View Details
2,2,3,3,3-Pentafluoro-1-propanol Cas:422-05-9 manufacturer 3,4-Difluoronitrobenzene manufacturer 2-methoxy-4-(4-acetylpiperazinyl)aniline manufacturer 4-Amino-3-hydroxybenzoic acid manufacturer Cyano temozolomide manufacturer